Seroatlas · Human Serome Atlas

PON2

Serum paraoxonase/arylesterase 2

Also known as: PON2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15165
Gene
PON2
Ensembl
ENSG00000105854
Chromosome
7
Canonical length
354 aa
Protein class
Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted to blood
Quaternary structure
Homotrimer

OverviewNCBI Gene

This gene encodes a member of the paraoxonase gene family, which includes three known members located adjacent to each other on the long arm of chromosome 7. The encoded protein is ubiquitously expressed in human tissues, membrane-bound, and may act as a cellular antioxidant, protecting cells from oxidative stress. Hydrolytic activity against acylhomoserine lactones, important bacterial quorum-sensing mediators, suggests the encoded protein may also play a role in defense responses to pathogenic bacteria. Mutations in this gene may be associated with vascular disease and a number of quantitative phenotypes related to diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

354 residues, UniProt reviewed canonical sequence.

>Q15165|PON2
     1  MGRLVAVGLL GIALALLGER LLALRNRLKA SREVESVDLP HCHLIKGIEA GSEDIDILPN
    61  GLAFFSVGLK FPGLHSFAPD KPGGILMMDL KEEKPRAREL RISRGFDLAS FNPHGISTFI
   121  DNDDTVYLFV VNHPEFKNTV EIFKFEEAEN SLLHLKTVKH ELLPSVNDIT AVGPAHFYAT
   181  NDHYFSDPFL KYLETYLNLH WANVVYYSPN EVKVVAEGFD SANGINISPD DKYIYVADIL
   241  AHEIHVLEKH TNMNLTQLKV LELDTLVDNL SIDPSSGDIW VGCHPNGQKL FVYDPNNPPS
   301  SEVLRIQNIL SEKPTVTTVY ANNGSVLQGS SVASVYDGKL LIGTLYHRAL YCEL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PON2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
229 nTPM

Expression across tissuesHPA

Tissue

  • basal ganglia: 229 nTPM
  • amygdala: 205 nTPM
  • cerebral cortex: 185 nTPM
  • liver: 172 nTPM
  • midbrain: 160 nTPM
  • hippocampal formation: 135 nTPM

Single-cell type

  • bergmann glia: 476 nCPM
  • extravillous trophoblasts: 468 nCPM
  • astrocytes: 458 nCPM
  • myosatellite cells: 352 nCPM
  • alveolar cells type 1: 319 nCPM
  • alveolar cells type 2: 245 nCPM

Immune cell

  • myeloid DC: 34 nTPM
  • NK-cell: 8.9 nTPM
  • plasmacytoid DC: 8.2 nTPM
  • classical monocyte: 7.8 nTPM
  • gdT-cell: 5 nTPM
  • MAIT T-cell: 4.6 nTPM

Brain region

  • hypothalamus: 164 nTPM
  • basal ganglia: 152 nTPM
  • white matter: 147 nTPM
  • thalamus: 139 nTPM
  • midbrain: 136 nTPM
  • amygdala: 132 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.03
gnomAD pLI
0
gnomAD missense Z
0.76
DepMap mean gene effect
0.08
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of PON2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PON2 as an antibody target. Whether an autoantibody or antibody against PON2 could matter depends on whether native PON2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PON2 is annotated at the cell surface, where native PON2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label PON2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PON2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...